Tirzepatide tirzepatide is a synthetic peptide composed of 39 amino acids and belongs to a novel class of metabolic agents known as dual incretin receptor agonists. It is designed to simultaneously activate both the glp-1 glucagon-like peptide-1 and gip glucose-dependent insulinotropic polypeptide receptors, providing a dual-target approach for metabolic and obesity-related research. 2 Mg 50 mg 100 mg and 120 mg is oem option and it is only available for bulk order. Mechanism of action glp-1 receptor activation supports glucose-dependent insulin secretion. Reduces appetite and food intake through enhanced satiety signaling. Slows gastric emptying, contributing to prolonged fullness. Facilitates the study of glucose metabolism and energy balance. Gip receptor activation enhances insulin sensitivity and pancreatic beta-cell function. Works synergistically with glp-1 receptor activation to improve metabolic regulation. Supports investigations into lipid metabolism and energy utilization. Research applications tirzepatide has attracted significant interest in scientific research due to its dual-incretin mechanism and potential effects on: body weight regulation appetite and satiety pathways glucose homeostasis insulin sensitivity metabolic syndrome research obesity and diabetes-related studies energy expenditure and fat metabolism product characteristics synthetic peptide 39 amino acid sequence dual receptor agonist glp-1 gip high purity for laboratory applications suitable f...
NasvitaWebDelivery 1-4 days$ 195.00